This lends support to the notion that eNOS may exert its metabolic benefits in an AMPK-dependent manner and play an important role in scenarios where metabolism and/or energy state is perturbed, i.e., obesity/NAFLD (Figure 1). Here, NOS3 is linked to obesity due to melanocortin 4 receptor deficiency.